 Selectas ImmTORTM platform enhances transgene expression and addresses adeno-associated virus AAV vector immunogenicity constraints to deliver transformative therapies Selectas ImmTORTM platform enhances transgene expression and addresses adeno-associated virus AAV vector immunogenicity constraints to deliver transformative therapies 